MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 584-591

  Shih, Tsung Chieh ^a   Tien, Yin Jing ^c   Wen, Chih Jen ^a   Yeh, Ta Sen ^a   Yu, Ming Chin ^a   Huang, Chia Hao ^b   Lee, Yun Shien ^a,d   Yen, Tzu Chen ^a   Hsieh, Sen Yung ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^d MING CHUAN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Hepatoma; Hepatoma derived growth factor; Hypervascularity; MicroRNA; MiR 214; Paracrine

Indexed keywords

HEPATOMA DERIVED GROWTH FACTOR; MICRORNA 214;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL STRAIN HEK293; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; PROGNOSIS;

EID: 84865107292     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.031     Document Type: Article

References (37)

1. A.X. Zhu, D.G. Duda, D.V. Sahani, and R.K. Jain HCC and angiogenesis: possible targets and future directions Nat Rev Clin Oncol 8 2011 292 301
2. M. Fernandez, D. Semela, J. Bruix, I. Colle, M. Pinzani, and J. Bosch Angiogenesis in liver disease J Hepatol 50 2009 604 620
3. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
4. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
5. T.A. Kerr, K.M. Korenblat, and N.O. Davidson MicroRNAs and liver disease Transl Res 157 2011 241 252
6. S. Huang, and X. He The role of microRNAs in liver cancer progression Br J Cancer 104 2011 235 240
7. K. Kojima, A. Takata, C. Vadnais, M. Otsuka, T. Yoshikawa, and M. Akanuma MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma Nat Commun 2 2011 338
8. J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
9. L. Liang, C.M. Wong, Q. Ying, D.N. Fan, S. Huang, and J. Ding MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2 Hepatology 52 2010 1731 1740
10. C.C. Wong, C.M. Wong, E.K. Tung, S.L. Au, J.M. Lee, and R.T. Poon The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2 Gastroenterology 140 2011 322 331
11. S. Shimizu, T. Takehara, H. Hikita, T. Kodama, T. Miyagi, and A. Hosui The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma J Hepatol 52 2010 698 704
12. J.F. Zhang, M.L. He, W.M. Fu, H. Wang, L.Z. Chen, and X. Zhu Primate-specific miRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting stat3 signaling Hepatology 54 2011 2137 2148
13. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658 (Pubitemid 47187346)
14. B. Wang, S. Majumder, G. Nuovo, H. Kutay, S. Volinia, and T. Patel Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice Hepatology 50 2009 1152 1161
15. L. Gramantieri, F. Fornari, M. Ferracin, A. Veronese, S. Sabbioni, and G.A. Calin MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality Clin Cancer Res 15 2009 5073 5081
16. S. Toffanin, Y. Hoshida, A. Lachenmayer, A. Villanueva, L. Cabellos, and B. Minguez MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a Gastroenterology 140 2011 1618 1628 e1616
17. J.H. Fang, H.C. Zhou, C. Zeng, J. Yang, Y. Liu, and X. Huang MicroRNA-29b suppresses tumor angiogenesis, invasion and metastasis by regulating MMP-2 expression Hepatology 54 2011 1729 1740
18. L. Gramantieri, F. Fornari, E. Callegari, S. Sabbioni, G. Lanza, and C.M. Croce MicroRNA involvement in hepatocellular carcinoma J Cell Mol Med 12 2008 2189 2204
19. A. van Mil, S. Grundmann, M.J. Goumans, Z. Lei, M.I. Oerlemans, and S. Jaksani MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release Cardiovasc Res 93 2012 655 665
20. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, and E. Quaglino MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C EMBO J 30 2011 1990 2007
21. T. Ueda, S. Volinia, H. Okumura, M. Shimizu, C. Taccioli, and S. Rossi Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis Lancet Oncol 11 2010 136 146
22. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, and J. Wang MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433 (Pubitemid 351380068)
23. Y. Feng, J.H. Cao, X.Y. Li, and S.H. Zhao Inhibition of miR-214 expression represses proliferation and differentiation of C2C12 myoblasts Cell Biochem Funct 29 2011 378 383
24. L.M. Li, D.X. Hou, Y.L. Guo, J.W. Yang, Y. Liu, and C.Y. Zhang Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes J Immunol 186 2011 2552 2560
25. P.T. Jindra, J. Bagley, J.G. Godwin, and J. Iacomini Costimulation- dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten J Immunol 185 2010 990 997
26. A.H. Juan, R.M. Kumar, J.G. Marx, R.A. Young, and V. Sartorelli Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells Mol Cell 36 2009 61 74
27. G. Yin, R. Chen, A.B. Alvero, H.H. Fu, J. Holmberg, and C. Glackin TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214 Oncogene 29 2010 3545 3553
28. H. Chen, R. Shalom-Feuerstein, J. Riley, S.D. Zhang, P. Tucci, and M. Agostini MiR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro Biochem Biophys Res Commun 394 2010 921 927
29. S. Boyault, D.S. Rickman, A. de Reynies, C. Balabaud, S. Rebouissou, and E. Jeannot Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52 (Pubitemid 46144363)
30. H. Enomoto, K. Yoshida, Y. Kishima, Y. Okuda, and H. Nakamura Participation of hepatoma-derived growth factor in the regulation of fetal hepatocyte proliferation J Gastroenterol 37 2002 158 161 (Pubitemid 35385950)
31. S. Yamamoto, Y. Tomita, Y. Hoshida, S. Takiguchi, Y. Fujiwara, and T. Yasuda Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma Clin Cancer Res 12 2006 117 122 (Pubitemid 43166184)
32. K. Yoshida, Y. Tomita, Y. Okuda, S. Yamamoto, H. Enomoto, and H. Uyama Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma Ann Surg Oncol 13 2006 159 167 (Pubitemid 43157409)
33. Y. Zhou, N. Zhou, W. Fang, and J. Huo Over expressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer Diagn Pathol 5 2010 58
34. Y.F. Liu, R. Zhao, S. Guo, X.Q. Wang, P.L. Lian, and Y.G. Chen Expression and Clinical Significance of Hepatoma-Derived Growth Factor as a Prognostic Factor in Human Hilar Cholangiocarcinoma Ann Surg Oncol 18 2011 872 879
35. H. Ren, Z. Chu, and L. Mao Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer Mol Cancer Ther 8 2009 1106 1112
36. K.C. Chang, M.H. Tai, J.W. Lin, C.C. Wang, C.C. Huang, and C.H. Hung Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors Int J Cancer 121 2007 1059 1065
37. H. Uyama, Y. Tomita, H. Nakamura, S. Nakamori, B. Zhang, and Y. Hoshida Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer Clin Cancer Res 12 2006 6043 6048 (Pubitemid 44703767)